What GPs need to know about melanoma patients on systemic therapies | 26mins
In the last decade, the treatment landscape for melanoma has been transformative for patients with advanced disease. Although managed primarily by medical oncologists, it is important for GPs to be across which treatments are available for their patients as they are often the first point of contact when a patient becomes unwell.
In this podcast, Medical Oncologist Professor Georgina Long discusses how systemic therapy is used in the treatment of advanced melanoma, and how a GP can identify and manage toxicities in patients being treated with targeted or immunotherapies.
This podcast is suitable for GPs, Skin Cancer GPs, nurses and other healthcare professionals.
Subscribe to our new Melanoma Insights for Professionals podcasts via iTunes or Spotify or for Android devices, click here or search for 'Melanoma Insights for Professionals' your favourite podcast app.
Professor Georgina Long
Co-Medical Director and Chair of Melanoma Medical Oncology and Translational Research, Melanoma Institute Australia and Royal North Shore Hospital, The University of Sydney
Head of Education, Melanoma Institute Australia
- Outline how systemic therapy is used in the treatment of advanced melanoma.
- Identify toxicities in your melanoma patients undergoing treatment with targeted or immunotherapies, and understanding how to manage and when to refer.